1,834 results on '"Eriksson, A. I."'
Search Results
752. Enhancement of electric and magnetic wave fields at density gradients
753. Electric field measurements on Cluster: comparing the double-probe and electron drift techniques
754. Assessment of Bleeding after Concomitant Administration of Antiplatelet and Anticoagulant Agents in Lower Limb Arthroplasty
755. Oral Anticoagulants in Development
756. Low-energy (order 10 eV) ion flow in the magnetotail lobes inferred from spacecraft wake observations
757. Thromboembolism in Orthopedic Surgery: Scope of the Problem.
758. Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin
759. Prevention of Venous Thromboembolism after Total Hip Replacement with Once-Daily BAY 59-7939 - An Oral, Direct Factor Xa Inhibitor.
760. Thromboprophylaxis after Orthopaedic Surgery with an Oral, Direct Factor Xa Inhibitor: Pooled Results of Two Phase Iib Clinical Trials.
761. VENUS - A Study To Validate Centrally Adjudicated Venous Ultrasound Against Venography after Major Orthopaedic Surgery.
762. Midazolam depresses carotid body chemoreceptor activity
763. Effect of prolonged mechanical ventilation on diaphragm muscle mitochondria in piglets
764. Cassini Measurements of Cold Plasma in the Ionosphere of Titan
765. Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement
766. Effects of neuromuscular blocking agents on central respiratory chemosensitivity in newborn rats
767. Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery
768. Precession of the whistler polarisation plane normal observed on Freja
769. Quantifying Diaphragm Function with Ultrasound: Development in a Piglet Model of Diaphragm Fatigue
770. Effect of Propofol on Carotid Body Chemosensitivity and Cholinergic Chemotransduction
771. Subacute versus delayed reconstruction of the anterior cruciate ligament in the competitive athlete.
772. Complications following arthroscopic anterior cruciate ligament reconstruction. A 2-5-year follow-up of 604 patients with special emphasis on anterior knee pain.
773. Serial magnetic resonance imaging of the donor site after harvesting the central third of the patellar tendon. A prospective study of 37 patients after arthroscopic anterior cruciate ligament reconstruction.
774. Reconstruction of the anterior cruciate ligament: comparison of outside-in and all-inside techniques.
775. Fondaparinux
776. Efficacy of fondaparinux for thromboprophylaxis in hip fracture patients
777. Localization of wave fields in lower hybrid cavities
778. Observations of lower hybrid cavities in the inner magnetosphere by the Cluster and Viking satellites
779. Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points
780. Neuromuscular blocking agents block carotid body neuronal nicotinic acetylcholine receptors
781. Excitation of Localized Rotating Waves in Plasma Density Cavities by Scattering of Fast Magnetosonic Waves
782. Changes in diaphragm structure following prolonged mechanical ventilation in piglets
783. Fiber-type composition and fiber size of the human cricopharyngeal muscle and the pharyngeal constrictor muscle
784. Lower‐hybrid cavity density depletions as a result of transverse ion acceleration localized on the gyroradius scale
785. Neuromuscular Monitoring Advancement: In Reply
786. Studies of new stainless steels and products with application of new welding processes
787. Ion energization mechanisms at 1700 km in the auroral region
788. Feeding and Respiration.
789. Fondaparinux and Prolonged Thromboprophylaxis After Hip Fracture Surgery—Reply
790. New Pentasaccharides for the Prophylaxis of Venous Thromboembolism
791. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery
792. Fondaparinux, the first selective factor Xa inhibitor
793. Improvements in the Prevention of Postoperative Venous Thromboembolism in Hip Fracture Patients
794. Persistence of the risk of venous thromboembolism (VTE) for at least four weeks after hip fracture surgery: evidence from the fondaparinux hip fracture surgery database
795. Consistency of efficacy of extended thromboprophylaxis with fondaparinux (Arixtra) in prevention of venous thromboembolism (VTE) after hip fracture surgery according to different composite efficacy endpoints: the PENTHIFRA-PLUS study
796. Clinical experience of melagatran/ximelagatran in major orthopaedic surgery
797. Duration of Prophylaxis Against Venous Thromboembolism With Fondaparinux After Hip Fracture SurgeryA Multicenter, Randomized, Placebo-Controlled, Double-blind Study
798. Observations of auroral broadband emissions by CLUSTER
799. Evidence-based Practice and Neuromuscular Monitoring
800. Reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.